Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia

Author: File Thomas M.   Milkovich Gary   Tennenberg Alan M.   Xiang Jim X.   Khashab Mohammed M.   Zadeikis Neringa  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.20, Iss.9, 2004-09, pp. : 1473-1481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content